BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38126155)

  • 1. cAMP-phosphodiesterase 4D7 (PDE4D7) forms a cAMP signalosome complex with DHX9 and is implicated in prostate cancer progression.
    Gulliver C; Busiau T; Byrne A; Findlay JE; Hoffmann R; Baillie GS
    Mol Oncol; 2024 Mar; 18(3):707-725. PubMed ID: 38126155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human phosphodiesterase 4D7 (PDE4D7) expression is increased in TMPRSS2-ERG-positive primary prostate cancer and independently adds to a reduced risk of post-surgical disease progression.
    Böttcher R; Henderson DJ; Dulla K; van Strijp D; Waanders LF; Tevz G; Lehman ML; Merkle D; van Leenders GJ; Baillie GS; Jenster G; Houslay MD; Hoffmann R
    Br J Cancer; 2015 Nov; 113(10):1502-11. PubMed ID: 26575822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cAMP phosphodiesterase-4D7 (PDE4D7) is downregulated in androgen-independent prostate cancer cells and mediates proliferation by compartmentalising cAMP at the plasma membrane of VCaP prostate cancer cells.
    Henderson DJ; Byrne A; Dulla K; Jenster G; Hoffmann R; Baillie GS; Houslay MD
    Br J Cancer; 2014 Mar; 110(5):1278-87. PubMed ID: 24518597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of Cyclic Adenosine Monophosphate Phosphodiesterase-4D7 for its Independent Contribution to Risk Stratification in a Prostate Cancer Patient Cohort with Longitudinal Biological Outcomes.
    Alves de Inda M; van Strijp D; den Biezen-Timmermans E; van Brussel A; Wrobel J; van Zon H; Vos P; Baillie GS; Tennstedt P; Schlomm T; Houslay MD; Bangma C; Hoffmann R
    Eur Urol Focus; 2018 Apr; 4(3):376-384. PubMed ID: 28753810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Creating a potential diagnostic for prostate cancer risk stratification (InformMDx™) by translating novel scientific discoveries concerning cAMP degrading phosphodiesterase-4D7 (PDE4D7).
    Henderson DJP; Houslay MD; Bangma CH; Hoffmann R
    Clin Sci (Lond); 2019 Jan; 133(2):269-286. PubMed ID: 30683712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human PDE4D isoform composition is deregulated in primary prostate cancer and indicative for disease progression and development of distant metastases.
    Böttcher R; Dulla K; van Strijp D; Dits N; Verhoef EI; Baillie GS; van Leenders GJ; Houslay MD; Jenster G; Hoffmann R
    Oncotarget; 2016 Oct; 7(43):70669-70684. PubMed ID: 27683107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The activity of cAMP-phosphodiesterase 4D7 (PDE4D7) is regulated by protein kinase A-dependent phosphorylation within its unique N-terminus.
    Byrne AM; Elliott C; Hoffmann R; Baillie GS
    FEBS Lett; 2015 Mar; 589(6):750-5. PubMed ID: 25680530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The DNA/RNA helicase DHX9 contributes to the transcriptional program of the androgen receptor in prostate cancer.
    Chellini L; Pieraccioli M; Sette C; Paronetto MP
    J Exp Clin Cancer Res; 2022 May; 41(1):178. PubMed ID: 35590370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Association of the Long Prostate Cancer Expressed PDE4D Transcripts to Poor Patient Outcome Depends on the Tumour's TMPRSS2-ERG Fusion Status.
    van Strijp D; de Witz C; Heitkötter B; Huss S; Bögemann M; Baillie GS; Houslay MD; Bangma C; Semjonow A; Hoffmann R
    Prostate Cancer; 2019; 2019():8107807. PubMed ID: 31275657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of PDE4D7 expression promotes androgen independence, neuroendocrine differentiation and alterations in DNA repair: implications for therapeutic strategies.
    Gulliver C; Huss S; Semjonow A; Baillie GS; Hoffmann R
    Br J Cancer; 2023 Oct; 129(9):1462-1476. PubMed ID: 37740039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloning and characterization of novel PDE4D isoforms PDE4D6 and PDE4D7.
    Wang D; Deng C; Bugaj-Gaweda B; Kwan M; Gunwaldsen C; Leonard C; Xin X; Hu Y; Unterbeck A; De Vivo M
    Cell Signal; 2003 Sep; 15(9):883-91. PubMed ID: 12834813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotoxic stress inhibits Ewing sarcoma cell growth by modulating alternative pre-mRNA processing of the RNA helicase DHX9.
    Fidaleo M; Svetoni F; Volpe E; Miñana B; Caporossi D; Paronetto MP
    Oncotarget; 2015 Oct; 6(31):31740-57. PubMed ID: 26450900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Host DHX9 DExH-Box Helicase Is Recruited to Chikungunya Virus Replication Complexes for Optimal Genomic RNA Translation.
    Matkovic R; Bernard E; Fontanel S; Eldin P; Chazal N; Hassan Hersi D; Merits A; Péloponèse JM; Briant L
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30463980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced PDE4D7 in prostate cancer correlates with genomic downregulation within the upstream PDE4D coding region.
    Gulliver C; Baillie GS; Hoffmann R
    Future Sci OA; 2023 Oct; 9(9):FSO888. PubMed ID: 37752916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The biology of DHX9 and its potential as a therapeutic target.
    Lee T; Pelletier J
    Oncotarget; 2016 Jul; 7(27):42716-42739. PubMed ID: 27034008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poxviral protein E3-altered cytokine production reveals that DExD/H-box helicase 9 controls Toll-like receptor-stimulated immune responses.
    Dempsey A; Keating SE; Carty M; Bowie AG
    J Biol Chem; 2018 Sep; 293(39):14989-15001. PubMed ID: 30111593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Nup98 regulates the localization and activity of DExH/D-box helicase DHX9.
    Capitanio JS; Montpetit B; Wozniak RW
    Elife; 2017 Feb; 6():. PubMed ID: 28221134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular RNA Helicase DHX9 Interacts with the Essential Epstein-Barr Virus (EBV) Protein SM and Restricts EBV Lytic Replication.
    Fu W; Verma D; Burton A; Swaminathan S
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30541834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The DNA/RNA helicase DHX9 orchestrates the KDM2B-mediated transcriptional regulation of YAP1 in Ewing sarcoma.
    Chellini L; Scarfò M; Bonvissuto D; Sette C; Paronetto MP
    Oncogene; 2024 Jan; 43(4):225-234. PubMed ID: 38017132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of a Primary Screening Assay for the DHX9 Helicase.
    Cencic R; Senechal P; Pelletier J
    Comb Chem High Throughput Screen; 2015; 18(9):855-61. PubMed ID: 26477352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.